|
ИСТИНА |
Войти в систему Регистрация |
ИСТИНА ПсковГУ |
||
Towards Integrated Bio Design-Related and Translational Platforms to Determine Co-Development for Adaptation of Innovative Biotechnologies and to Predict and to Prognosticate the Future of the Healthcare and Life Science Bioindustryстатья
- Авторы: Medvedeva V., Rose N., Blokh S., Zemskov A., Khlynoskii A., Zemskov V., Miller A.D., Kovalev M., Andronova N., Kobrinskii B., Grigorieva T., Moiseyakh M., Cheng R.H., Suchkov S.
- Журнал: American Journal of Biomedical Science & Research
- Том: 7
- Номер: 3
- Год издания: 2022
- Издательство: BiomedGrid, LLC
- Местоположение издательства: Orange, CA, USA
- Первая страница: 66
- Последняя страница: 73
- DOI: 10.34297/ajbsr.2022.17.002352
- Аннотация: We are used to consider innovations in the life sciences and healthcare services as being discovery- and design-driven ones. And across worldwide basic, translational, clinical, and applied re-search, and throughout the bioindustries, scientific breakthroughs have been the launching point for principal bioproduct developments in the translational trajectory. Even the most innovative healthcare technologies being translated in the right direction, would provide patient benefits only when adopted by clinicians and/or patients in actual practice. So, co-development between innovation-related builders and customers is a key agile principle. And in the coming wave of innovation in the broad-scope applications, learning rapidly what new bioproduct features work well for clinicians and patients will become even more crucial.Accelerating innovation to improve quality is a key policy target for healthcare systems around the world. And policies that aim to support this process should seek to control the wider conditions that nurture peer-to-peer influence. The advanced design-based translational research into interpersonal influence in health settings may improve implementation of change initiatives. So, promoting innovation within national health systems has been set as a key target for health care professionals and policy makers in the civilized world and has led to the establishment of several innovation pathways to encourage the invention, development and implementation of cost-effective technologies that improve health care delivery. These pathways operate at different stages of the innovation pipeline, with their scope and work defined by location, technology area or bioindustry sector, based on the specific problem identified when they were set up.Due to the worldwide experience and practice say, the efficiency and efficacy of the national economy are determined and dictated by the innovative trends, generated by fresh knowledge and their transfer into the scientific, industrial, and social areas to maintain the national stability and extensive development of the country. So, we would have to have the life sciences deeper understood to be re-shaping tomorrow’s healthcare whilst doing it today!
- Добавил в систему: Кобринский Борис Аркадьевич